1-20 of 38
K Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5812: Histone deacetylase 10 supports tumor growth under polyamine-limiting conditions

Tracy Murray Stewart, Raphael R. Steimbach, Jackson R. Foley, Aubry K. Miller, Robert A. Casero
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5812.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5812
Published: 15 June 2022
View article
Journal Articles

Abstract A031: Dissecting the role of the bone ecosystem and intrinsic resistance in the evolution of refractory multiple myeloma

Anna K. Miller, Ryan T. Bishop, Tao Li, Conor C. Lynch, David Basanta
Journal: Cancer Research
Cancer Res (2022) 82 (10_Supplement): A031.
DOI: https://doi.org/10.1158/1538-7445.EVODYN22-A031
Published: 15 May 2022
View article
Journal Articles

Abstract OT3-02-07: PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

O Metzger, S Mandrekar, S Loibl, C Mundhenke, S Seiler, P Valagussa, E Lim, D Tripathy, EP Winer, C Huang, L Carey, P Francis, K Miller, MP Goetz, A Prat, S Loi, I Krop, L Gianni, S Delalogue, I Vaz-Luis, T Dockter, J Lanzillotti, E Ciruelos, AM DeMichele
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): OT3-02-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-OT3-02-07
Published: 15 February 2019
View article
Journal Articles

Abstract P1-12-14: Quality of life, fear of recurrence, impact of cancer, and dietary habits in breast cancer patients during the early survivorship period - Initial data from the pilot Cas-PET (Cancer Survivorship Patient Engagement Toolkit) study

PY Rosenblatt, M McQuaige, K Miller, E-S Nahm, L Hertsenberg
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P1-12-14.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-P1-12-14
Published: 15 February 2019
View article
Journal Articles

Abstract P3-08-16: ER, PR and HER2 biomarkers in UK and Irish clinical breast cancer testing: analysis of results from >168,000 patients

A Dodson, S Parry, M Ibrahim, J Bartlett, M Dowsett, K Miller
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P3-08-16.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P3-08-16
Published: 15 February 2018
View article
Journal Articles

Abstract OT3-05-08: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

E Mayer, A DeMichele, M Gnant, W Barry, G Pfeiler, O Metzger, H Burstein, K Miller, P Rastogi, S Loibl, T Goulioti, D Zardavas, C Fesl, M Koehler, C Huang-Bartlett, X Huang, M Piccart, E Winer, A Wolff
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): OT3-05-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-OT3-05-08
Published: 15 February 2018
View article
Journal Articles

Abstract OT3-05-07: PATINA: A randomized open label phase III trial to evaluate the efficacy and safety of palbociclib + anti HER2 therapy + endocrine therapy vs anti HER2 therapy + endocrine therapy after induction treatment for hormone receptor positive, HER2 positive metastatic breast cancer

O Metzger-Filho, S Mandrekar, S Loibl, E Ciruelos, L Gianni, E Lim, K Miller, C Huang, M Koehler, P Francis, P Valagussa, S Goel, A Prat, M Goetz, S Loi, I Krop, L Carey, J Lanzillotti, E Winer, D Tripathy, A DeMichele
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): OT3-05-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-OT3-05-07
Published: 15 February 2018
View article
Journal Articles

Abstract P1-03-01: An international multicenter study to evaluate reproducibility of automated scoring methods for assessment of Ki67 in breast cancer

DL Rimm, LM McShane, SCY Leung, Y Bai, AL Bane, JMS Bartlett, J Bayani, MC Chang, M Dean, C Denkert, E Enwere, C Galderisi, A Gholap, JC Hugh, A Jadhav, E Kornaga, A Laurinavicius, R Levenson, J Lima, K Miller, L Pantanowitz, T Piper, J Ruan, M Srinivasan, S Virk, Y Wu, H Yang, DF Hayes, TO Nielsen, M Dowsett
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P1-03-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-03-01
Published: 15 February 2017
View article
Journal Articles

Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer

I Krop, J Cortes, K Miller, MT Huizing, L Provencher, L Gianni, S Chan, M Trudeau, J Steinberg, J Sugg, M Liosatos, VE Paton, A Peterson, A Wardley
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P4-22-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P4-22-08
Published: 15 February 2017
View article
Journal Articles

Abstract P4-21-40: In vitro and in vivo activity of HER2-targeted antibody-liposomal doxorubicin conjugate MM-302 in HER2-intermediate tumors

E Geretti, C Espelin, B Adiwijaya, S Coma, Z Koncki, P Sumner, N Dumont, G Garcia, T Bloom, J Janovsky, J Reynolds, K Campbell, V Moyo, I Molnar, P LoRusso, I Krop, K Miller, C Ma, P Munster, T Wickham
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P4-21-40.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P4-21-40
Published: 15 February 2017
View article
Journal Articles

Abstract P6-12-04: Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer

A Forero-Torres, S Modi, J Specht, K Miller, A Weise, H Burris, III, M Liu, I Krop, L Pusztai, A Kostic, M Li, M Mita
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P6-12-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P6-12-04
Published: 15 February 2017
View article
Journal Articles

Abstract P3-07-25: Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: prognosis or prediction?

K Miller, I Krop, L Schwartzberg, V Abramson, L Garcia-Estevez, J Eakle, R Nanda, D Yardley, F Ademuyiwa, S Chan, J Crown, M Danso, K Gelmon, L Ma, N Martinez-Janez, W Gradishar, J Steinberg, IC Tudor, H Uppal, VE Paton, J Parker, CA Hudis, TA Traina
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-07-25.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-07-25
Published: 15 February 2016
View article
Journal Articles

Abstract P3-14-05: Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer

A Forero, H Burris III, M Mita, J Specht, A Weise, MC Liu, S Modi, L Pusztai, A Kostic, J Yang, M Li, S Hengel, K Miller
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-14-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-14-05
Published: 15 February 2016
View article
Journal Articles

Abstract OT1-03-21: PALLAS: PAlbociclib Collaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer

E Mayer, A DeMichele, P Dubsky, W Barry, O Metzger, WF Symmans, H Burstein, K Miller, A Wolff, P Rastogi, S Loibl, G von Minckwitz, T Goulioti, D Zardavas, C Fesl, M Koehler, C Huang Bartlett, L Chen, M Piccart, E Winer, M Gnant
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT1-03-21.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-21
Published: 15 February 2016
View article
Journal Articles

Abstract OT3-01-01: HERMIONE: A phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician's choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and ado-trastuzumab emtansine (T-DM1)

K Miller, J Cortes, SA Hurvitz, IE Krop, D Tripathy, S Verma, K Riahi, JG Reynolds, T Wickham, I Molnar, DA Yardley
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT3-01-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT3-01-01
Published: 15 February 2016
View article
Journal Articles

Abstract OT2-01-04: E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group

R Connolly, F Zhao, K Miller, A Tevaarwerk, L Wagner, M Lee, J Murray, R Gray, R Piekarz, JA Zujewski, J Sparano
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT2-01-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT2-01-04
Published: 15 February 2016
View article
Journal Articles

Abstract P1-01-16: Performance evaluation of two ready-to-use antibodies under development for the Dako Omnis automated staining platform on breast carcinoma specimens: Anti-estrogen receptor α clone EP1 and anti-progesterone receptor clone PgR 1294

G Viale, P Dell'Orto, M Falzon, A Fält, D Hicks, K Hoff, K Jakobsen, LB Jensen, YY Levy, L McMahon, K Miller, L Russo
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P1-01-16.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P1-01-16
Published: 15 February 2016
View article
Journal Articles

Abstract OT3-1-07: MotHER: A US registry for women with breast cancer who have received trastuzumab, pertuzumab in combination with trastuzumab, or trastuzumab emtansine (T-DM1) during pregnancy or within 7 months prior to conception

Vikki Brown, Richard K Miller, Laura Chu, Cheryl Chow, Caroline Trudeau, Elizabeth B Andrews
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): OT3-1-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-OT3-1-07
Published: 01 May 2015
View article
Journal Articles

Abstract OT3-2-01: A phase 2 randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of enzalutamide in combination with exemestane in estrogen or progesterone receptor-positive and HER2 non-amplified advanced breast cancer

DA Yardley, A Awada, J Cortes, HA Burris, A Peterson, S Bhattacharya, L Gianni, K Miller, E Winer
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): OT3-2-01.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-OT3-2-01
Published: 15 December 2013
View article
Journal Articles

Abstract P4-12-29: Assessment of safety and activity in an expanded phase 1 study of MM-302, a HER2-targeted liposomal doxorubicin, in patients with advanced HER2-positive (HER2+) breast cancer

P Munster, IE Krop, K Miller, N Dhindsa, C Niyijiza, U Nielsen, A Odueyungbo, A Rajarethinam, M Marande, K Campbell, E Geretti, JG Reynolds, BS Hendriks, T Wickham, V Moyo, P LoRusso
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): P4-12-29.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-P4-12-29
Published: 15 December 2013
View article